Translating The GOLD COPD Guidelines Into Primary Care Practice (LungAge)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01237561|
Recruitment Status : Completed
First Posted : November 9, 2010
Last Update Posted : April 4, 2017
|Condition or disease||Intervention/treatment|
|Chronic Obstructive Pulmonary Disease (COPD)||Other: provider support tools plus spirometer|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||3593 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Translating The GOLD COPD Guidelines Into Primary Care Practice|
|Actual Study Start Date :||October 2010|
|Primary Completion Date :||October 25, 2013|
|Study Completion Date :||October 25, 2013|
Experimental: spirometry, patient activation tool
Other: provider support tools plus spirometer
Patient Activation Tool, Provider Web-based decision support tool, academic detailing
Other Name: Determine the effectiveness of tools developed in improving guideline implementation and adherence.
No Intervention: Usual Care
Spirometer and spirometry training of staff
- Adherence to COPD guidelines [ Time Frame: Twelve months post intervention ]An adherence tool will be developed and reviewed by an expert panel. They will review the suggested criterion and make recommendations regarding an item's status on the tool. The panel may also suggest additional criteria for inclusion in the tool. The tool will be modified based on expert consensus. Once the tool is finalized, a detailed algorithm will be developed for scoring the primary care practice data which will include an adherence score for each visit and an overall adherence score and will be piloted the first 2 months of chart review.
- patient activation [ Time Frame: Baseline and 12 months post intervention ]A patient activation measure (PAM) developed by Hibbard et al. will be used to assess a patient's knowledge, skills and behaviors necessary to create an activated patient for managing their own health care. The patient activation tool will also measure other co-morbidities and will be assessed during a telephone survey at baseline and on a subsample 12 months post-intervention.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01237561
|United States, Rhode Island|
|Memorial Hospital of Rhode Island|
|Pawtucket, Rhode Island, United States, 02860|
|Principal Investigator:||Donna R Parker, Sc.D.||MHRhode Island|